Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults.
about
P53-MDM2 Pathway: Evidences for A New Targeted Therapeutic Approach in B-Acute Lymphoblastic LeukemiaTreatment of Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia.The promise of Janus kinase inhibitors in the treatment of hematological malignancies.MicroRNA-144 regulates cancer cell proliferation and cell-cycle transition in acute lymphoblastic leukemia through the interaction of FMN2.
P2860
Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults.
@en
type
label
Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults.
@en
prefLabel
Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults.
@en
P2093
P2860
P1476
Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults.
@en
P2093
Aharon Ronson
Ariella Tvito
Jacob M Rowe
P2860
P2888
P356
10.1007/S11912-016-0519-8
P577
2016-06-01T00:00:00Z
P6179
1007260796